Investigational New Drug - redOrbit

News - Investigational New Drug

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

2012-05-29 02:27:26

SAN DIEGO, May 29, 2012 /PRNewswire/ -- Marshall Edwards, Inc.

Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies

2012-05-22 02:27:56

BOONTON, N.J., May 22, 2012 /PRNewswire/ -- Unigene Laboratories, Inc.

Ampio Pharmaceuticals Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion(TM) for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders

2012-05-11 02:23:25

GREENWOOD VILLAGE, Colo., May 11, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Tengion Provides Business Update and Reports First Quarter 2012 Financial Results

2012-05-07 10:24:59

WINSTON-SALEM, N.C., May 7, 2012 /PRNewswire/ -- Tengion, Inc.

Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidate ME-344

2012-04-10 02:27:47

SAN DIEGO, April 10, 2012 /PRNewswire/ -- Marshall Edwards, Inc.

More News (412 articles) »